or
Bookmark and Share
Sustained release of hydrochlorothiazide
   
Document Number
US Patent 3901971
Issued Date
August 26, 1975
Link
Map
Abstract
A sustained release pharmaceutical composition which includes hydrochlorothiazide and a polymer of a monomer mixture of a monoester of acrylic acid and/or methacrylic acid and a polyhydric alcohol; sulfur containing compound; and a diester of acrylic and/or methacrylic acid.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
18
Comments:
no comments yet
Owner
Union Corporation (Verona, PA)
Published
August 26, 1975
Application Number
05/395,689
Filed
September 10, 1973
US Classification
514/223.2   424/486 514/772.6
Int'l Classification
A61K   9/20   (20060101)  
Examiner
USPTO Field of Search
424/19   424/20   424/21   424/22   424/81  
Related Patents
4150110 - Coated granules of polyacrylic alkali metal salts and method of producing same - Owned by Nippon Kayaku Kabushiki Kaisha (Tokyo,JP)

Granules of polyacrylic alkali metal salts are coated with a water-insoluble but water-permeable coating agent.

4981852 - Chemical compounds triamterene and hydrochlorothiazide - Owned by Multilan AG (CH)

A diuretic pharmaceutically acceptable solution of triamterene and solutions of triamterene and hydrochlorothiazide to provide an antihypertensive and diuretic effect for those in need thereof. Triamterene is solubilized in a combination of a glycol and lactic acid present in an amount sufficient to maintain the triamterene in solution. A pharmaceutically acceptable diluent, such as glycerin is also present.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us